Cataract surgery with systemic co-morbidity: is perioperative management necessary?

Session Details

Session Title: Ocular Infections & Other Topics

Session Date/Time: Sunday 15/09/2019 | 08:00-10:00

Paper Time: 09:00

Venue: Free Paper Forum: Podium 4

First Author: : D.Joshi INDIA

Co Author(s): :    S. Joshi   S. Marathe                          

Abstract Details

Purpose:

To assess the perioperative management (monitoring and interventions) required for patients who have undergone cataract surgeries with respect to specific systemic co-morbidities and to suggest preferred practices for managing systemic co-morbidity or illness while performing cataract surgeries in patients at nuclear facilities and tertiary hospitals.

Setting:

Eye Department of a City-Based Tertiary Care Multispeciality Hospital

Methods:

Hospital records of 2022 patients undergoing cataract surgery over a period of two years were analyzed retrospectively. Of these, 519 were found to have systemic co morbidities & were included in this study. Data was analyzed to determine the perioperative management (monitoring and interventions) required for these patients with respect to their specific systemic co morbidity.

Results:

The mean age in this study group was 68 years of which 199 patients (38.3%) were females & 320(61.7%) were males. A wide spectrum of comorbidities was observed which included Cardiovascular disease(most common) & Hypertension,Malignancies,Renal disorders, Respiratory disorders, etc. Among these patients, 511 (98.5%) did not require any preoperative interventions.30 patients(5.8%) required intra-operative interventions like Intravenous Injection Metoprolol, Midazolam, Atropine etc. Only 02 patients (0.2%) required post op intervention relevant to the comorbidity. 17 patients (3.3%)required sedation during the surgery. None of the patients required overnight hospitalisation for monitoring or intervention of the comorbidity.

Conclusions:

Most patients with systemic disorders do not require perioperative interventions pertinent to these and can easily undergo safe cataract surgery under local anaesthesia at standalone or nuclear centres in a resource limited setup.

Financial Disclosure:

None